Andere Sprachen Blackstone Inc.

Aktien

A2PM4W

US09260D1072

BX

Investitionsmanagement & Fondsbetreiber

Markt geschlossen - Nyse 22:00:02 08.05.2026 % 5 Tage Veränd. 1. Jan.
123.77 USD +1.18% Intraday Chart für Blackstone Inc. -2.04% -19.70%

Andere Sprachen

08.05. Sector Update: Financial Stocks Decline Late Afternoon
08.05. Apollo, Blackstone in Talks on $35 Billion Financing for Broadcom
08.05. Apollo and Blackstone weigh $35 billion financing for Broadcom - Bloomberg News
08.05. Apollo, Blackstone Mull $35 Billion Financing for Broadcom, Bloomberg Reports
08.05. Nvidia, Apple, Exxon CEOs to Be Invited on Trump's China Trip
08.05. Private credit roundup: HSBC's big loss and an FSB warning
08.05. Blackstone-Led Lenders Plan $100 Million Capital Injection Into Medallia
07.05. Trading Day: Markets draw breath
07.05. Trump assembles delegation of US corporate giants for upcoming China visit
07.05. Blackstone, I Squared Near $2.9 Billion Bid for Stroeer
07.05. MarineMax presses on with sale process as Donerail raises its bid, sources say
07.05. Trump administration invites Nvidia, Boeing CEOs for China trip, report says
07.05. Nvidia, Apple, Exxon CEOs to Be Invited on Trump's China Trip
07.05. Trump administration plans to invite CEOs from Nvidia, Apple, Exxon on Trump's China trip, report says
07.05. Trump Administration Plans to Invite Firms' CEOs on China Trip, Semafor Reports
07.05. Trump administration plans to invite CEOs from Nvidia, Apple, Exxon on China trip - Semafor
07.05. Blackstone, I Squared Near $2.9 Billion Bid for Stroeer
07.05. Blackstone, I Squared Nearing $2.9 Billion Bid for Stroeer, Bloomberg Reports
07.05. Blackstone, BlackRock cut value of their private credit funds
07.05. Blackstone Unit Invests $250 Million to Support Anagram Therapeutics' Treatment for Exocrine Pancreatic Insufficiency
07.05. Blackstone cuts value of private credit fund in first quarter
07.05. Blackstone Life Sciences invests $250 million in Anagram Therapeutics to advance novel and patient-friendly oral enzyme replacement therapy for pancreatic insufficiency
07.05. Blackstone Life Sciences Invests $250 Million in Anagram Therapeutics to Advance Novel and Patient-Friendly Oral Enzyme Replacement Therapy for Pancreatic Insufficiency
07.05. Blackstone Secured Lending portfolio discount widens as unrealized losses rise
07.05. Tritax Big Box REIT optimistic as it progresses data centre pipeline
Keine Ergebnisse zu dieser Suche